Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...
GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...
Vizient, Inc. released its new Spend Management Outlook representing the best estimate of the change in the price of pharmaceuticals, medical devices and supplies, capital equipment and services ...
Get dialed in every Tuesday & Friday with quick updates on the world of crypto ...
A stunning underwater park, one of Europe's most exciting new attractions for diving lovers, is set to open in Greece in 2025. The diving park, already under construction, is located on the island of ...